ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to have a visual discussion about all of the possible outcomes of breast augmentation. Our revolutionary artistic platform gives the surgeon the perfect opportunity to create the ideal size and shape for every possible situation. The best part is that now the surgeon and patient will share the same visual expectation of surgery, and equally important, have a mutual understanding of the limitations of surgery based on the patients unique anatomy. Remember, ILLUSIO is primarily an artistic tool created to manage patient expectations. With ILLUSIO, the overall time per consult could become shorter and patients could make decisions quicker and with much more confidence. Above all, they will have fun with the process. The ability to look into our Virtual Mirror and see themselves with their virtual breasts is new and exciting and provides a real Wow experience. As patients become engaged in the process they will very likely want to share their ILLUSIO experience with their friends and family. Source
No articles found.
Mediclinic International owns and operates hospitals and medical facilities. The H...
Mediclinic International owns and operates hosp...
Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission...
Teligent is a specialty generic pharmaceutical ...
Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...
Marinus Pharmaceuticals, Inc. is committed to i...
Genmab is a publicly traded, international biotechnology company specializing in t...
Genmab is a publicly traded, international biot...
We are a biotechnology company developing novel immunotherapy treatments for cance...
We are a biotechnology company developing novel...
Agenus is an immuno-oncology company designed to deliver innovation with speed for...
Agenus is an immuno-oncology company designed t...
Currency Tracking Technologies (CTT) develops proprietary software applications an...
Currency Tracking Technologies (CTT) develops p...
Join the National Investor Network and get the latest information with your interests in mind.